Perrigo Co PLC (PRGO)

71.36
0.57 0.81
NYSE : Health Care
Prev Close 70.79
Open 70.79
Day Low/High 70.33 / 71.79
52 Wk Low/High 65.47 / 111.00
Volume 1.20M
Avg Volume 2.04M
Exchange NYSE
Shares Outstanding 143.37M
Market Cap 10.11B
P/E Ratio N/A
Div & Yield 0.64 (0.90%)

Latest News

Perrigo Announces Two New Independent Directors

Perrigo Announces Two New Independent Directors

New Directors Nominated by Starboard in Accordance With Previously Announced Agreement

Group Stink; Good, the Bad and the Ugly: Doug Kass' Views

Group Stink; Good, the Bad and the Ugly: Doug Kass' Views

Doug Kass shares his thoughts on Facebook, Allergan and Apple.

S&P 500 Lower After Fed Leaves Rates Unchanged, Dow Turns Higher

S&P 500 Lower After Fed Leaves Rates Unchanged, Dow Turns Higher

Stocks hold mostly lower on Wednesday after the Federal Reserve's policy-making group decides to leave its federal funds rate unchanged.

Generics Drop Across Board as DOJ Inquiry Expands

Generics Drop Across Board as DOJ Inquiry Expands

The addition of Perrigo to the list of generics makers under investigation is more bad news for a sector already under pressure from low prices.

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Perrigo Company Plc

SHAREHOLDER ALERT: Goldberg Law PC Announces An Investigation Of Perrigo Company Plc

Goldberg Law PC announces that it is investigating Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) concerning possible violations of federal securities laws.

PERRIGO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Perrigo Co. To Contact The Firm

PERRIGO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Perrigo Co. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Perrigo Co.

Perrigo Shares Fall After Disclosing DOJ Investigation

Perrigo Shares Fall After Disclosing DOJ Investigation

The search involves a Department of Justice Antitrust Division investigation in relation to drug pricing in the pharmaceutical industry

Stock Losses Deepen as Oil Tumbles, Apple Falls and Wall Street Awaits the Fed

Stock Losses Deepen as Oil Tumbles, Apple Falls and Wall Street Awaits the Fed

Stock losses deepen on Wednesday morning after crude oil turns negative and a decision from the Federal Reserve looms.

Perrigo Stock Sliding on DOJ Search

Perrigo Stock Sliding on DOJ Search

The investigation is in relation to drug pricing in the pharmaceutical industry.

Perrigo Discloses Investigation

Perrigo Discloses Investigation

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Why Mylan, Perrigo and Endo Won't Be Playing Spoiler in Akorn-Fresenius Tie Up

Fresenius announced a deal to buy U.S. generic drugmaker Akorn Inc for $4.75 billion, or $34 per share.

Perrigo Announces Restatement Of Previously Issued Forms 10-K And 10-Q Financial Statements; Announces Select Preliminary Unaudited First Quarter 2017 Financial Results

Perrigo Announces Restatement Of Previously Issued Forms 10-K And 10-Q Financial Statements; Announces Select Preliminary Unaudited First Quarter 2017 Financial Results

- Tysabri® historical royalty stream determined to be a financial asset; Company to file 2016 Form 10-K, including restated fiscal 2014, fiscal 2015 and transition period 2015 audited financials and certain quarterly financial information as soon as practical

Judgment Day; The Good, the Bad and the Ugly: Doug Kass' Views

Judgment Day; The Good, the Bad and the Ugly: Doug Kass' Views

Doug Kass shares his thoughts on whether Judgment Day is here for the financials and discusses General Electric, Apple and Caterpillar.

The New #102 Most Shorted S&P 500 Component: Perrigo Company

The New #102 Most Shorted S&P 500 Component: Perrigo Company

The most recent short interest data has been released for the 03/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Perrigo Company Becomes #209 Most Shorted S&P 500 Component, Replacing Flowserve

Perrigo Company Becomes #209 Most Shorted S&P 500 Component, Replacing Flowserve

The most recent short interest data has been released for the 03/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members

Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members

The Street took a look at the top 15 activist hedge funds and their director-election records over the past six years

Perrigo Provides Update On 2016 Form 10-K Filing

Perrigo Provides Update On 2016 Form 10-K Filing

- Continues to work with independent auditor, and expects to file its Form 10-K as soon as practical

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Investors are deciding what to make of an impending overhaul of the American health care system in the wake of legislative progress out of Washington.

Mylan's Governance May Be the Root of Its Problems

Mylan's Governance May Be the Root of Its Problems

The scandals plaguing the pharmaceutical company can be traced to lack of change at the board level.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving The Board Of Perrigo Company Plc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving The Board Of Perrigo Company Plc

Levi & Korsinsky announces it has commenced an investigation of Perrigo Company plc (NYSE:PRGO).